share_log
Breakings ·  Aug 13 19:57
Galectin Therapeutics: Navigate Trial on Track for Interim Top-Line Analysis in December 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment